Operating Expenses Summary of Grifols, S.A.

Grifols, S.A.'s latest annual operating expenses in 2023 was 1.69 Billion EUR , up 3.63% from previous year.
Grifols, S.A.'s latest quarterly operating expenses in 2024 Q1 was 444.75 Million EUR , down -4.72% from previous quarter.
Grifols, S.A. reported a annual operating expenses of 1.52 Billion EUR in annual operating expenses 2022, up 9.23% from previous year.
Grifols, S.A. reported a annual operating expenses of 1.4 Billion EUR in annual operating expenses 2021, up 9.4% from previous year.
Grifols, S.A. reported a quarterly operating expenses of 368.36 Million EUR for 2024 Q2, down -13.02% from previous quarter.
Grifols, S.A. reported a quarterly operating expenses of 379.44 Million EUR for 2023 Q2, down -5.09% from previous quarter.

Annual Operating Expenses Chart of Grifols, S.A. (2023 - 2005)

Historical Annual Operating Expenses of Grifols, S.A. (2023 - 2005)

Year	Operating Expenses	Operating Expenses Growth
2023	1.69 Billion EUR	3.63%
2022	1.52 Billion EUR	9.23%
2021	1.4 Billion EUR	9.4%
2020	1.27 Billion EUR	5.0%
2019	1.21 Billion EUR	15.48%
2018	1.05 Billion EUR	-8.12%
2017	1.14 Billion EUR	18.07%
2016	972.88 Million EUR	1.28%
2015	960.62 Million EUR	14.15%
2014	841.52 Million EUR	23.44%
2013	681.73 Million EUR	1.82%
2012	669.51 Million EUR	-36.37%
2011	1.05 Billion EUR	89.57%
2010	555 Million EUR	7.54%
2009	516.1 Million EUR	25.82%
2008	410.19 Million EUR	16.72%
2007	351.43 Million EUR	-2.23%
2006	359.44 Million EUR	17.22%
2005	306.65 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	444.75 Million EUR	-4.72%
2024 Q2	368.36 Million EUR	-13.02%
2023 Q2	379.44 Million EUR	-5.09%
2023 Q3	388.76 Million EUR	2.46%
2023 FY	1.58 Billion EUR	3.63%
2023 Q1	399.77 Million EUR	-7.65%
2023 Q4	466.78 Million EUR	20.07%
2022 Q1	333.06 Million EUR	-11.6%
2022 FY	1.52 Billion EUR	9.23%
2022 Q4	432.9 Million USD	16.45%
2022 Q3	371.75 Million EUR	-5.33%
2022 Q2	392.67 Million EUR	17.9%
2021 Q1	328.95 Million EUR	-3.84%
2021 Q3	376.75 Million EUR	11.93%
2021 Q2	336.59 Million EUR	2.32%
2021 FY	1.4 Billion EUR	9.4%
2021 Q4	376.75 Million USD	0.0%
2020 Q3	311.25 Million EUR	1.05%
2020 FY	1.27 Billion EUR	5.0%
2020 Q1	318.45 Million EUR	-1.0%
2020 Q2	308.02 Million EUR	-3.27%
2020 Q4	342.09 Million EUR	9.91%
2019 Q2	286.62 Million EUR	-3.48%
2019 Q4	321.67 Million EUR	2.59%
2019 FY	1.21 Billion EUR	15.48%
2019 Q1	296.97 Million EUR	0.02%
2019 Q3	313.56 Million EUR	9.4%
2018 Q2	255.73 Million EUR	4.69%
2018 Q1	244.28 Million EUR	-22.85%
2018 FY	1.05 Billion EUR	-8.12%
2018 Q3	258.49 Million EUR	1.08%
2018 Q4	296.92 Million EUR	14.87%
2017 FY	1.14 Billion EUR	18.07%
2017 Q4	316.62 Million EUR	18.73%
2017 Q3	266.68 Million EUR	-3.44%
2017 Q2	276.17 Million EUR	-4.5%
2017 Q1	289.18 Million EUR	13.29%
2016 Q1	242.72 Million EUR	-9.85%
2016 Q2	246.44 Million EUR	1.53%
2016 Q3	228.43 Million EUR	-7.31%
2016 FY	972.88 Million EUR	1.28%
2016 Q4	255.27 Million EUR	11.75%
2015 Q3	235.25 Million EUR	-2.54%
2015 Q1	214.74 Million EUR	-0.76%
2015 FY	960.62 Million EUR	14.15%
2015 Q2	241.38 Million EUR	12.41%
2015 Q4	269.24 Million EUR	14.44%
2014 Q4	216.37 Million EUR	1.55%
2014 FY	841.52 Million EUR	23.44%
2014 Q3	213.07 Million EUR	-1.0%
2014 Q2	215.22 Million EUR	9.33%
2014 Q1	196.85 Million EUR	8.04%
2013 Q4	182.2 Million EUR	7.62%
2013 FY	681.73 Million EUR	1.82%
2013 Q1	162.58 Million EUR	-9.73%
2013 Q2	167.63 Million EUR	3.11%
2013 Q3	169.3 Million EUR	0.99%
2012 Q3	162.3 Million EUR	-2.81%
2012 Q2	166.99 Million EUR	4.29%
2012 Q1	160.11 Million EUR	-76.63%
2012 FY	669.51 Million EUR	-36.37%
2012 Q4	180.1 Million EUR	10.97%
2011 Q3	149.84 Million EUR	-0.11%
2011 Q4	685.09 Million EUR	357.21%
2011 FY	1.05 Billion EUR	89.57%
2011 Q1	67.2 Million EUR	-82.05%
2011 Q2	150 Million EUR	123.2%
2010 FY	555 Million EUR	7.54%
2010 Q4	374.37 Million EUR	557.4%
2010 Q3	-81.85 Million EUR	0.0%
2009 FY	516.1 Million EUR	25.82%
2008 FY	410.19 Million EUR	16.72%
2007 FY	351.43 Million EUR	-2.23%
2006 FY	359.44 Million EUR	17.22%
2005 FY	306.65 Million EUR	0.0%

Peer Operating Expenses Comparison of Grifols, S.A.

Name	Operating Expenses	Operating Expenses Difference
AstraZeneca PLC	29.57 Billion USD	94.269%
Bristol-Myers Squibb Company PFD CONV 2	17.07 Billion USD	90.07%
CSPC Pharmaceutical Group Limited	2.14 Billion USD	21.043%
Clarus Therapeutics Holdings, Inc.	50.96 Million USD	-3225.89%
Novartis AG	24.87 Billion USD	93.184%
PT Kalbe Farma Tbk.	11823.24 Billion USD	99.986%

Global Stocks Search

Grifols, S.A. (GIKLY)

Operating Expenses Summary of Grifols, S.A.

Annual Operating Expenses Chart of Grifols, S.A. (2023 - 2005)

Historical Annual Operating Expenses of Grifols, S.A. (2023 - 2005)

Peer Operating Expenses Comparison of Grifols, S.A.